GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Debt-to-Equity

J.Molner AS (OTSE:MOLNR) Debt-to-Equity : 8.29 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Debt-to-Equity?

J.Molner AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.27 Mil. J.Molner AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €1.91 Mil. J.Molner AS's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €0.26 Mil. J.Molner AS's debt to equity for the quarter that ended in Dec. 2023 was 8.29.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for J.Molner AS's Debt-to-Equity or its related term are showing as below:

OTSE:MOLNR' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.87   Med: 4.95   Max: 8.29
Current: 8.29

During the past 3 years, the highest Debt-to-Equity Ratio of J.Molner AS was 8.29. The lowest was -1.87. And the median was 4.95.

OTSE:MOLNR's Debt-to-Equity is ranked worse than
98.47% of 848 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs OTSE:MOLNR: 8.29

J.Molner AS Debt-to-Equity Historical Data

The historical data trend for J.Molner AS's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Debt-to-Equity Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Debt-to-Equity
-1.87 4.95 8.29

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Equity -1.87 2.31 4.95 1.33 8.29

Competitive Comparison of J.Molner AS's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, J.Molner AS's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


J.Molner AS's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.Molner AS's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where J.Molner AS's Debt-to-Equity falls into.



J.Molner AS Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

J.Molner AS's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

J.Molner AS's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


J.Molner AS  (OTSE:MOLNR) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


J.Molner AS Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


J.Molner AS (OTSE:MOLNR) Business Description

Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines